Facilitated By

San Antonio Medical Foundation

METHYLENE BLUE: A NOVEL DISEASE-MODIFYING DRUG FOR EARLY INTERVENTION IN PARKINSON'S DISEASE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Clark,Robert A
Funded by
WILLIAM & ELLA OWENS MED RSCH FOUNDATION
Research Start Date
Status
Active
Clinical Care
Aging
Neuroscience